These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10670214)

  • 1. [Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs].
    Rogolino A; Farsi A; Brunelli T; Ilari I; Capanni M; Domeneghetti MP; Dorigo W; Lombardi R; Pulli R; Pratesi C; Gensini GF
    Minerva Cardioangiol; 1999 Dec; 47(12):583. PubMed ID: 10670214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiopulmonary baroreceptors activity and skin microcirculation in patients with peripheral obliterative arteriopathy].
    De Marchi S; Zannoni M; Prior M; Lucchese L; Arosio E; Lechi A
    Minerva Cardioangiol; 1999 Dec; 47(12):586-8. PubMed ID: 10670216
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of infusion treatment once a day for 4 weeks with alprostadil-alpha-cyclodextrin on blood levels of endothelin-1 in patients with chronic obliterative arteriopathy of the legs at Leriche-Fontaine stage 2].
    Mangiafico RA; Malatino LS; Attinà T; Dell'Arte S; Messina R
    Minerva Cardioangiol; 1999 Dec; 47(12):652-3. PubMed ID: 10670246
    [No Abstract]   [Full Text] [Related]  

  • 4. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.
    Asfar S; Safar HA
    J Cardiovasc Surg (Torino); 2007 Oct; 48(5):601-5. PubMed ID: 17989630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
    Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial pressure in the toes of patients with obliterative arteriopathy of the legs].
    Di Nardo E; Spigonardo F; Kester G; Hinkley J; Romolo M; Iapadre P; Zecchini F; Possati F
    Ann Ital Chir; 1984; 56(1):81-6. PubMed ID: 6476657
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of leg and body position on transcutaneous oxygen measurements in healthy subjects and subjects with peripheral artery disease after lower-extremity arterial revascularization: a pilot study.
    Rich K
    J Vasc Nurs; 2002 Dec; 20(4):125-35; quiz 136-7. PubMed ID: 12469073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Moderate hyperhomocysteinemia: physiopathology of the endothelial lesion and its clinical implications].
    Falcón CR; Carreras LO
    Sangre (Barc); 1998 Feb; 43(1):47-54. PubMed ID: 9577181
    [No Abstract]   [Full Text] [Related]  

  • 10. Leucocyte-endothelial interactions in chronic critical limb ischaemia.
    Ciuffetti G; Lombardini R; Pasqualini L; Vaudo G
    Ann Ital Med Int; 1996; 11(3):170-4. PubMed ID: 8950845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
    di Giovanna VN
    Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atherogenic risk factors in patients with obliterative arteriopathy of the legs].
    Scannapieco G; Parisi R; Bortoluzzi C; Doria S; Puato M; Ambrosio GB
    Minerva Cardioangiol; 1999 Dec; 47(12):579-80. PubMed ID: 10670212
    [No Abstract]   [Full Text] [Related]  

  • 13. Homocysteine in myointimal hyperplasia.
    Hansrani M; Gillespie JI; Stansby G
    Eur J Vasc Endovasc Surg; 2002 Jan; 23(1):3-10. PubMed ID: 11748941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obliterative arteriopathy of the legs associated with a vasculopathy of the supra-aortic trunk].
    Bolognini G; Iezzi BG
    Minerva Cardioangiol; 1985 Dec; 33(12):855-7. PubMed ID: 3912680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leukocyte rheology and controlled ischemia in peripheral obliterative vascular diseases].
    Ciuffetti G; Mannarino E; Lombardini R; Pasqualini L; Scarponi AM; Palazzetti D; Mercuri M; Lupattelli G
    Ric Clin Lab; 1989; 19 Suppl 1():95-7. PubMed ID: 2629096
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrite plasma levels in normolipemic and hypercholesterolemic patients with peripheral occlusive arteriopathy.
    Ferlito S; Gallina M; Catassi S; Bisicchia A; Di Salvo MM
    Panminerva Med; 1999 Dec; 41(4):307-9. PubMed ID: 10705710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained elevation of circulating vascular endothelial growth factor after percutaneous angioplasty for peripheral arterial diseases.
    Liu TJ; Lai HC; Ting CT; Lee WL
    Int J Cardiol; 2006 Mar; 107(3):415-6. PubMed ID: 16503265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic physical exercise in the preoperative preparation of patients with obliterative vascular diseases of the legs].
    Kulikov IuA; Dzhuraeva LA; Avazmatova KhR; Ismailova DA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (1):53-5. PubMed ID: 2711639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.